ATRX — Adhera Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Adhera Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	3.92	0.05	0.001	0.076	0.032
Net Total Accounts Receivable
Net Total Receivables	0.048	0	—	—	—
Total Inventory
Prepaid Expenses
Total Current Assets	4.68	0.42	0.001	0.196	0.079
Net Property, Plant And Equipment	0.072	0	—	—	—
Net Goodwill
Net Intangible Assets
Total Assets	5.14	0.42	0.001	0.196	0.079
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.21	10.3	14.8	25.3	22.3
Total Long Term Debt
Total Debt
Total Liabilities	2.21	10.3	14.8	25.3	22.3
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	2.93	-9.89	-14.8	-25.1	-22.2
Total Liabilities & Shareholders' Equity	5.14	0.42	0.001	0.196	0.079
Total Common Shares Outstanding
Total Preferred Shares Outstanding